HOLBROOK, N.Y., June 18, 2014 /PRNewswire/ -- Northstar
Global Business Services, Inc., Symbol (OTCPink:MDIN) today
announced that the company's CEO, Justin
Sindelman, will be appearing on the popular internet radio
show, Pot Stock radio, at http://tinyurl.com/pjcc4aw on
Monday, June 23rd at
8pm EST. Also appearing on the show
will be Megan Schwarting of Kush
Creams, to discuss the recent deal with Northstar and the evolution
of both industries that the companies represent. The show's host,
Eric Butz, will interview Mr.
Sindelman and Ms. Schwarting for approximately one hour. During the
interview, both companies intend to share exciting information
about their plans moving forward.
Northstar and Kush Creams recently announced a deal, which now
looks more like a straight licensing deal than a manufacturing and
distribution deal; designed to help insulate Northstar from the
unknowns associated with the massive amount of laws and regulations
surrounding the medical and recreational marijuana industry. The
arrangement has Kush Creams, one of the top legal marijuana
producers in the country, producing and distributing Snorenz
Medicated, and Snorenz Night Time Medicated, throughout
Washington State. The Medicated
versions of the popular seller, Snorenz is infused with THC, the
active ingredient in Marijuana. Since a non-Washington resident company cannot manufacture
or transport THC containing products, Northstar is lending the
brand to Kush creams in exchange for a per sale licensing so that
the product can hit dispensary shelves in the near future.
"We are ecstatic that Snorenz will be one of the first main
stream brands to step over into the medical and recreational
marijuana industry, and we believe that although this may seem like
a bold move now, in the near future it will be common place.
Northstar will be one of the first though, and this is perfectly in
line with the tempo we aspire to set. Breaking new ground and
pushing forward is one of the traits that will help Northstar to
become a household name," commented Mr. Sindelman.
The new Snorenz Medicated will be the first product to hit
shelves, and will be available in the coming weeks. The companies
have carefully laid plans to rapidly distribute throughout
Washington State, mainly thanks to
Kush Creams and the elaborate, fast growing distribution network
that they already have in place.
About Northstar
Northstar Global Business Services is dedicated to producing the
best alternative healthcare products to the world. The company's
products include Snorenz®, Good Night's Sleep®, Stem-Intense, and
more. Most of the company's products use a unique or patented spray
delivery system, and all have received rave consumer reviews all
over the world, selling millions of units from 1996 to the present.
www.medgeninc.com.
About Kush Creams:
Kush Creams is a nationwide leader and industry pioneer in medical
cannabis topical pain relief. Founded in 2010 in Washington state, the company has quickly and
successfully grown to serve the thriving medical marijuana
marketplace and the newly emerging legal cannabis market. Kush
Creams currently manufactures an extensive line of over the counter
and prescription strength products and has won over a dozen
industry awards. www.kushcreams.com.
DISCLAIMER
This Press Release may contain certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. The Company has tried, whenever possible, to identify
these forward-looking statements using words such as "anticipates,"
"believes," "estimates," "expects," "plans," "intends," "potential"
and similar expressions. These statements reflect the Company's
current beliefs and are based upon information currently available
to it. Accordingly, such forward-looking statements involve known
and unknown risks, uncertainties and other factors which could
cause the Company's actual results, performance or achievements to
differ materially from those expressed in or implied by such
statements. The Company undertakes no obligation to update or
advise in the event of any change, addition or alteration to the
information catered in this Press Release including such
forward-looking statements.
CONTACT: Investor Relations, investors@medgeninc.com,
877-571-4387
SOURCE Northstar Global Business Services